Epigenetics Market Report
The Global Epigenetics Market report is segmented By Product (Reagents [Antibodies, Magnetic Beads, Histones, Buffers, Primers, Others], Kits [Chip sequencing kit, Whole Genomic Amplification kit, Bisulfite Conversion kit, RNA sequencing kit, Others], Instruments [Next-Generation Sequencers, Qpcr Instruments, Mass Spectrometers, Sonicators, Others], Enzymes [DNA-Modifying Enzymes [Protein-Modifying Enzymes, RNA-Modifying Enzymes], Services), By Technology (DNA Methylation, Histone Methylation, Histone Acetylation, Large non - coding RNA, MicroRNA modification, Chromatin structures), By Application (Oncology [Solid tumors, Liquid tumors], Non – oncology [Inflammatory diseases, Metabolic diseases, Infectious diseases, Cardiovascular diseases, Others) and Region. The report also covers COVID-19 Impact Analysis and Forecast to 2026.
This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global epigenetics market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2026.
The Global Epigenetics Market report is segmented By Product (Reagents [Antibodies, Magnetic Beads, Histones, Buffers, Primers, Others], Kits [Chip sequencing kit, Whole Genomic Amplification kit, Bisulfite Conversion kit, RNA sequencing kit, Others], Instruments [Next-Generation Sequencers, Qpcr Instruments, Mass Spectrometers, Sonicators, Others], Enzymes [DNA-Modifying Enzymes [Protein-Modifying Enzymes, RNA-Modifying Enzymes], Services), By Technology ...
Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.
Note: The summary below might not have included insights on covid impact since we have large number of reports.
The Global Epigenetics Market is projected to grow from USD 5.9 billion in 2020 to USD 17.2 billion by 2026 at a CAGR of over 19.5% during the forecast period.
Figure: Global Epigenetics Market Size, 2020-2026 (USD Billion)
Wish to receive a full scope of the report? Click Here…
Epigenetics is referred to a stream of genetics that involves the study of physiological and cellular trait variations initiated by external or ecological aspects, which turns genes on and off and affects the cellular ability to read the genes without being impacted by changes in genotype. It results in changes in the phenotype of an organism rather than the genotype, where the underlying RNA or DNA sequence remains unchanged. Epigenetic alterations are vital for development as they are dynamic and change as per the surrounding environment stimuli.
Key players operating in the global epigenetics market are-
The growing prevalence of cancer and other chronic diseases coupled with the increasing aging population is expected to bolster the product demand.
Based on product, the global epigenetics market has been segmented into reagents, kits, instruments, enzymes, and services.
By region, the North American market accounted for the largest market share of over 40% in 2020 and is likely to grow at a steady CAGR during the review period.
The COVID-19 pandemic has moderately affected the epigenetics industry. Few therapeutic combinations have been studies to cure this viral infection. Researchers have analyzed how epigenetics may prevent viral proliferation so that vaccines and therapeutics for COVID- 19 can be synthesized to specifically target replicating mechanisms of a virus. This, in turn, positively stimulates market growth.
Get the full scope of the report here....
The following is a list of the customers that the Epigenetics market aims to convert the most:
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].
The epigenetics market is expected to reach USD 17.2 billion in the foreseeable future.
Illumina, Inc. (The US), Merck Sharp & Dohme Corp (The US), Qiagen (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Eisai Co., Ltd. (Japan), Novartis AG (Switzerland), Abcam plc (UK), Diagenode Diagnostics (Belgium), Active Motif (The US), Zymo Research Corporation (The US), and CellCentric (UK) are among the key players in the epigenetics market.
The epigenetics market is expected to witness an impressive growth of 19.5% CAGR in the coming years.
Growing prevalence of cancer and other chronic diseases coupled with the increasing aging population, various initiatives such as the Epidemiology and Genomics Research Program (EGRP), increasing need to understand epigenetic modifications at the molecular level and the advancement of therapeutic solutions are the factors driving the growth of epigenetics market.
North American market accounted for the largest market share of over 40% in 2020 and is likely to grow at a steady CAGR during the review period.
Reagents segment garnered the highest market share in 2020 and is likely to register a healthy CAGR during the assessment period.
Epigenetics treatment companies, Hospitals, Diagnostic Centers And Laboratories, Cancer organizations, Research Centers & Organizations are the target audience in the Epigenetics Market.